Ignite Creation Date:
2024-05-06 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 2:18 PM
Study NCT ID:
NCT05128019
Status:
COMPLETED
Last Update Posted:
2023-05-17
First Post:
2021-10-19
Brief Title:
Use of the Individual Challenge Inventory Tool ICIT by General Practitioners
Sponsor:
University of Oslo
Organization:
University of Oslo
Study Overview
Official Title:
Can the Use of the Conversation Tool Individual Challenge Inventory Tool ICIT by General Practitioners Increase Coping of the Patients
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ICIT
Brief Summary:
Many patients in general practice present symptoms that do not refer to specific pathology We refer to these patients at Medical Unexplained Physical Symptoms MUPS Practice and research have well documented that these patients frustrate most General Practitioners GPs They also produce a lot of unnecessary investigations and are overrepresented on sick-listing The conversational tool Individual Challenge Inventory Tool ICIT offers an aid for the GPS to the consultation and aims to increase the patients coping abilities with their health challenges The aim of the study is to investigate whether patients experience such increased coping following a session of consultations with their GP based on ICIT
Detailed Description:
The study is a Cluster Randomized Controlled Trial cRCT with GPs as clusters We plan to includ 50 GPs to participate as intervention group and 50 GPs as controls Each cluster will include 10 patients GPs in the intervention group will be trained in the use of ICIT through a 30 hours course partly digital and partly in presence The participants will receive lectures on the background for the conversation tool and the study and will practice on each other At the end of the study also the 50 GPs of the control group will be invited to an identical course
The outcome of the study is any changes of the patients coping abilities If the symptoms cannot be healed a goal for the patients will be to reduce the impact of the symptoms In practice this is to reuptake normal activities including work in spite of pain fatigue or mood disturbances Through the ICIT the patients will be challenged to look at themselves in a broader spectrum and decide for themselves which activities are possible to reuptake and making a thorough plan for doing so
The patients will be treated by their regular GP across several meetings and they will agree on a specific plan across weeks or months to achieve their individual goal
The patients of the GPs in the control group will represent identical medical symptoms and will be treated and followed by their GP as usual They will however be informed and asked to consign to participate in the study and will respond to the same questionnaires as the patients in the intervention group
The outcome of the study is any changes of the patients coping abilities If the symptoms cannot be healed a goal for the patients will be to reduce the impact of the symptoms In practice this is to reuptake normal activities including work in spite of pain fatigue or mood disturbances Through the ICIT the patients will be challenged to look at themselves in a broader spectrum and decide for themselves which activities are possible to reuptake and making a thorough plan for doing so
The patients will be treated by their regular GP across several meetings and they will agree on a specific plan across weeks or months to achieve their individual goal
The patients of the GPs in the control group will represent identical medical symptoms and will be treated and followed by their GP as usual They will however be informed and asked to consign to participate in the study and will respond to the same questionnaires as the patients in the intervention group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None